These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37894764)

  • 1. Readthrough Approach Using NV Translational Readthrough-Inducing Drugs (TRIDs): A Study of the Possible Off-Target Effects on Natural Termination Codons (NTCs) on TP53 and Housekeeping Gene Expression.
    Perriera R; Vitale E; Pibiri I; Carollo PS; Ricci D; Corrao F; Fiduccia I; Melfi R; Zizzo MG; Tutone M; Pace A; Lentini L
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsense codons suppression. An acute toxicity study of three optimized TRIDs in murine model, safety and tolerability evaluation.
    Corrao F; Zizzo MG; Tutone M; Melfi R; Fiduccia I; Carollo PS; Leonardo AD; Caldara G; Perriera R; Pace A; Belmonte B; Sammataro S; Pibiri I; Lentini L
    Biomed Pharmacother; 2022 Dec; 156():113886. PubMed ID: 36265311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies against Nonsense: Oxadiazoles as Translational Readthrough-Inducing Drugs (TRIDs).
    Campofelice A; Lentini L; Di Leonardo A; Melfi R; Tutone M; Pace A; Pibiri I
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the Inhibition of FTSJ1, a Tryptophan tRNA-Specific 2'-O-Methyltransferase by NV TRIDs, as a Mechanism of Readthrough in Nonsense Mutated CFTR.
    Carollo PS; Tutone M; Culletta G; Fiduccia I; Corrao F; Pibiri I; Di Leonardo A; Zizzo MG; Melfi R; Pace A; Almerico AM; Lentini L
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Affecting Readthrough of Natural Versus Premature Termination Codons.
    Beryozkin A; Nagel-Wolfum K; Banin E; Sharon D
    Adv Exp Med Biol; 2023; 1415():149-155. PubMed ID: 37440028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceuticals Promoting Premature Termination Codon Readthrough: Progress in Development.
    Li S; Li J; Shi W; Nie Z; Zhang S; Ma F; Hu J; Chen J; Li P; Xie X
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translation termination codons in protein synthesis and disease.
    Lombardi S; Testa MF; Pinotti M; Branchini A
    Adv Protein Chem Struct Biol; 2022; 132():1-48. PubMed ID: 36088072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stop codon context influences genome-wide stimulation of termination codon readthrough by aminoglycosides.
    Wangen JR; Green R
    Elife; 2020 Jan; 9():. PubMed ID: 31971508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Nonsense: Optimization of 1,2,4-Oxadiazole TRIDs to Rescue CFTR Expression and Functionality in Cystic Fibrosis Cell Model Systems.
    Pibiri I; Melfi R; Tutone M; Di Leonardo A; Pace A; Lentini L
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Insights into Determinants of Translational Readthrough and Implications for Nonsense Suppression Approaches.
    Lombardi S; Testa MF; Pinotti M; Branchini A
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A High-Throughput Assay for In Vitro Determination of Release Factor-Dependent Peptide Release from a Pretermination Complex by Fluorescence Anisotropy-Application to Nonsense Suppressor Screening and Mechanistic Studies.
    Ghelfi MD; Bhat SY; Li H; Cooperman BS
    Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A global analysis of the reconstitution of PTEN function by translational readthrough of PTEN pathogenic premature termination codons.
    Luna S; Torices L; Mingo J; Amo L; Rodríguez-Escudero I; Ruiz-Ibarlucea P; Erramuzpe A; Cortés JM; Tejada MI; Molina M; Nunes-Xavier CE; López JI; Cid VJ; Pulido R
    Hum Mutat; 2021 May; 42(5):551-566. PubMed ID: 33600059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum starvation enhances nonsense mutation readthrough.
    Wittenstein A; Caspi M; David Y; Shorer Y; Nadar-Ponniah PT; Rosin-Arbesfeld R
    J Mol Med (Berl); 2019 Dec; 97(12):1695-1710. PubMed ID: 31786671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic and quantitative analysis of stop codon readthrough in Rett syndrome nonsense mutations.
    Lebeda D; Fierenz A; Werfel L; Rosin-Arbesfeld R; Hofhuis J; Thoms S
    J Mol Med (Berl); 2024 May; 102(5):641-653. PubMed ID: 38430393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of new-generation aminoglycoside promoting premature termination codon readthrough in cancer cells.
    Bidou L; Bugaud O; Belakhov V; Baasov T; Namy O
    RNA Biol; 2017 Mar; 14(3):378-388. PubMed ID: 28145797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsense suppression therapies in human genetic diseases.
    Martins-Dias P; Romão L
    Cell Mol Life Sci; 2021 May; 78(10):4677-4701. PubMed ID: 33751142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The selective chemical modification of the 6-amino group of adenosine of the premature termination codon induces readthrough to produce full-length peptide in the reconstituted E. Coli translation system.
    Murase H; Lee J; Togo N; Taniguchi Y; Sasaki S
    Bioorg Med Chem; 2024 Sep; 111():117868. PubMed ID: 39137475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer syndromes and therapy by stop-codon readthrough.
    Bordeira-Carriço R; Pêgo AP; Santos M; Oliveira C
    Trends Mol Med; 2012 Nov; 18(11):667-78. PubMed ID: 23044248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in therapeutic use of a drug-stimulated translational readthrough of premature termination codons.
    Dabrowski M; Bukowy-Bieryllo Z; Zietkiewicz E
    Mol Med; 2018 May; 24(1):25. PubMed ID: 30134808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antimalarial drug mefloquine enhances TP53 premature termination codon readthrough by aminoglycoside G418.
    Ferguson MW; Gerak CAN; Chow CCT; Rastelli EJ; Elmore KE; Stahl F; Hosseini-Farahabadi S; Baradaran-Heravi A; Coltart DM; Roberge M
    PLoS One; 2019; 14(5):e0216423. PubMed ID: 31120902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.